PLRXPliant Therapeutics, Inc.

$82M

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$14M

Net Income

-$14M

EPS (Diluted)

$-0.61

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$312,000

Balance Sheet

Total Assets

$56M

Total Liabilities

$8M

Stockholders' Equity

$47M

Cash & Equivalents

$23M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$14M	-$6M	-130.4%
Net Income	-$14M	-$7M	-97.4%

PLRX Q1 2019 Earnings — Pliant Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena